Efficacy and Safety of Exogenous Ketones in People with Mild Neurocognitive Disorder and Alzheimer's Disease
This systematic review evaluated studies of medium-chain triglyceride and related ketogenic interventions in people with mild neurocognitive disorder or Alzheimer's disease. Some cognitive outcomes improved, but differences among studies limit firm conclusions.
Source: NIH PubMed (opens in a new tab)